(NOVC.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:NOVC - DK0060534915 - Common Stock
86.34 EUR
-2.03 (-2.3%)
NOVC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. While NOVC has a great profitability rating, there are some minor concerns on its financial health. NOVC is growing strongly while it is still valued neutral. This is a good combination! With these ratings, NOVC could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
- NOVC had positive earnings in the past year.
- In the past year NOVC had a positive cash flow from operations.
1.2 Ratios
- Looking at the Return On Assets, with a value of 23.95%, NOVC belongs to the top of the industry, outperforming 95.56% of the companies in the same industry.
- The Return On Equity of NOVC (74.32%) is better than 95.56% of its industry peers.
- NOVC has a better Return On Invested Capital (55.96%) than 97.78% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for NOVC is significantly above the industry average of 13.93%.
- The last Return On Invested Capital (55.96%) for NOVC is above the 3 year average (49.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.95% | ||
| ROE | 74.32% | ||
| ROIC | 55.96% |
ROA(3y)25.55%
ROA(5y)28.51%
ROE(3y)66.85%
ROE(5y)68.54%
ROIC(3y)49.65%
ROIC(5y)55.99%
1.3 Margins
- Looking at the Profit Margin, with a value of 33.40%, NOVC belongs to the top of the industry, outperforming 91.11% of the companies in the same industry.
- NOVC's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 42.80%, NOVC belongs to the best of the industry, outperforming 95.56% of the companies in the same industry.
- In the last couple of years the Operating Margin of NOVC has remained more or less at the same level.
- NOVC has a Gross Margin of 84.35%. This is amongst the best in the industry. NOVC outperforms 84.44% of its industry peers.
- NOVC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.8% | ||
| PM (TTM) | 33.4% | ||
| GM | 84.35% |
OM growth 3Y-0.97%
OM growth 5Y-0.64%
PM growth 3Y-0.57%
PM growth 5Y-1.67%
GM growth 3Y-0.02%
GM growth 5Y-0.07%
2. Health
2.1 Basic Checks
- NOVC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- NOVC has less shares outstanding than it did 1 year ago.
- NOVC has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 11.18 indicates that NOVC is not in any danger for bankruptcy at the moment.
- NOVC's Altman-Z score of 11.18 is amongst the best of the industry. NOVC outperforms 93.33% of its industry peers.
- The Debt to FCF ratio of NOVC is 0.38, which is an excellent value as it means it would take NOVC, only 0.38 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.38, NOVC belongs to the best of the industry, outperforming 91.11% of the companies in the same industry.
- NOVC has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
- NOVC's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. NOVC outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.38 | ||
| Altman-Z | 11.18 |
ROIC/WACC7.69
WACC7.28%
2.3 Liquidity
- A Current Ratio of 0.88 indicates that NOVC may have some problems paying its short term obligations.
- NOVC has a Current ratio of 0.88. This is amonst the worse of the industry: NOVC underperforms 84.44% of its industry peers.
- NOVC has a Quick Ratio of 0.88. This is a bad value and indicates that NOVC is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.70, NOVC is doing worse than 82.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
- NOVC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.68%.
- Measured over the past 5 years, NOVC shows a small growth in Earnings Per Share. The EPS has been growing by 3.48% on average per year.
- Looking at the last year, NOVC shows a very strong growth in Revenue. The Revenue has grown by 28.03%.
- Measured over the past years, NOVC shows a quite strong growth in Revenue. The Revenue has been growing by 9.64% on average per year.
EPS 1Y (TTM)-32.68%
EPS 3Y3.69%
EPS 5Y3.48%
EPS Q2Q%-26.37%
Revenue 1Y (TTM)28.03%
Revenue growth 3Y13.19%
Revenue growth 5Y9.64%
Sales Q2Q%31.59%
3.2 Future
- NOVC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.79% yearly.
- The Revenue is expected to grow by 13.65% on average over the next years. This is quite good.
EPS Next Y96.77%
EPS Next 2Y52.67%
EPS Next 3Y40.31%
EPS Next 5Y25.79%
Revenue Next Year27.56%
Revenue Next 2Y22.92%
Revenue Next 3Y20.4%
Revenue Next 5Y13.65%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 43.17, NOVC can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, NOVC is valued a bit more expensive than 64.44% of the companies in the same industry.
- NOVC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.32.
- The Price/Forward Earnings ratio is 15.13, which indicates a correct valuation of NOVC.
- Based on the Price/Forward Earnings ratio, NOVC is valued a bit cheaper than 64.44% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.32, NOVC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.17 | ||
| Fwd PE | 15.13 |
4.2 Price Multiples
- 64.44% of the companies in the same industry are cheaper than NOVC, based on the Enterprise Value to EBITDA ratio.
- NOVC's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.68 | ||
| EV/EBITDA | 30.33 |
4.3 Compensation for Growth
- NOVC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- NOVC has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as NOVC's earnings are expected to grow with 40.31% in the coming years.
PEG (NY)0.45
PEG (5Y)12.41
EPS Next 2Y52.67%
EPS Next 3Y40.31%
5. Dividend
5.1 Amount
- NOVC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap386.28B
Revenue(TTM)201.32B
Net Income(TTM)67.24B
Analysts70.63
Price Target169.94 (96.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP41.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.26%
Min EPS beat(2)-6.63%
Max EPS beat(2)2.11%
EPS beat(4)3
Avg EPS beat(4)-0.09%
Min EPS beat(4)-6.63%
Max EPS beat(4)2.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)99180.3%
Min Revenue beat(2)97265.9%
Max Revenue beat(2)101095%
Revenue beat(4)4
Avg Revenue beat(4)100079%
Min Revenue beat(4)97265.9%
Max Revenue beat(4)101151%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.68%
PT rev (3m)6.75%
EPS NQ rev (1m)-50.34%
EPS NQ rev (3m)-49.42%
EPS NY rev (1m)0.22%
EPS NY rev (3m)4.6%
Revenue NQ rev (1m)-99.9%
Revenue NQ rev (3m)-99.9%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)3.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.17 | ||
| Fwd PE | 15.13 | ||
| P/S | 14.31 | ||
| P/FCF | 42.68 | ||
| P/OCF | 32.1 | ||
| P/B | 31.84 | ||
| P/tB | 72.51 | ||
| EV/EBITDA | 30.33 |
EPS(TTM)2
EY2.32%
EPS(NY)5.71
Fwd EY6.61%
FCF(TTM)2.02
FCFY2.34%
OCF(TTM)2.69
OCFY3.12%
SpS6.03
BVpS2.71
TBVpS1.19
PEG (NY)0.45
PEG (5Y)12.41
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.95% | ||
| ROE | 74.32% | ||
| ROCE | 69.41% | ||
| ROIC | 55.96% | ||
| ROICexc | 79.18% | ||
| ROICexgc | 187.85% | ||
| OM | 42.8% | ||
| PM (TTM) | 33.4% | ||
| GM | 84.35% | ||
| FCFM | 33.53% |
ROA(3y)25.55%
ROA(5y)28.51%
ROE(3y)66.85%
ROE(5y)68.54%
ROIC(3y)49.65%
ROIC(5y)55.99%
ROICexc(3y)59.43%
ROICexc(5y)70.56%
ROICexgc(3y)107.14%
ROICexgc(5y)103.87%
ROCE(3y)66.16%
ROCE(5y)72.5%
ROICexgc growth 3Y12.28%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.96%
ROICexc growth 5Y-9.74%
OM growth 3Y-0.97%
OM growth 5Y-0.64%
PM growth 3Y-0.57%
PM growth 5Y-1.67%
GM growth 3Y-0.02%
GM growth 5Y-0.07%
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.38 | ||
| Debt/EBITDA | 0.21 | ||
| Cap/Depr | 278.9% | ||
| Cap/Sales | 11.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 100.38% | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 11.18 |
F-Score7
WACC7.28%
ROIC/WACC7.69
Cap/Depr(3y)235.6%
Cap/Depr(5y)244.27%
Cap/Sales(3y)10.33%
Cap/Sales(5y)10.26%
Profit Quality(3y)95.36%
Profit Quality(5y)92.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-32.68%
EPS 3Y3.69%
EPS 5Y3.48%
EPS Q2Q%-26.37%
EPS Next Y96.77%
EPS Next 2Y52.67%
EPS Next 3Y40.31%
EPS Next 5Y25.79%
Revenue 1Y (TTM)28.03%
Revenue growth 3Y13.19%
Revenue growth 5Y9.64%
Sales Q2Q%31.59%
Revenue Next Year27.56%
Revenue Next 2Y22.92%
Revenue Next 3Y20.4%
Revenue Next 5Y13.65%
EBIT growth 1Y29.73%
EBIT growth 3Y12.1%
EBIT growth 5Y8.94%
EBIT Next Year38.11%
EBIT Next 3Y23.19%
EBIT Next 5Y17.5%
FCF growth 1Y112.16%
FCF growth 3Y21.73%
FCF growth 5Y14.55%
OCF growth 1Y65.59%
OCF growth 3Y19.03%
OCF growth 5Y13.89%
/ NOVC.DE FAQ
What is the fundamental rating for NOVC stock?
ChartMill assigns a fundamental rating of 7 / 10 to NOVC.DE.
What is the valuation status of (NOVC.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to (NOVC.DE). This can be considered as Fairly Valued.
How profitable is (NOVC.DE) stock?
(NOVC.DE) has a profitability rating of 9 / 10.
What is the financial health of (NOVC.DE) stock?
The financial health rating of (NOVC.DE) is 7 / 10.
How sustainable is the dividend of (NOVC.DE) stock?
The dividend rating of (NOVC.DE) is 4 / 10 and the dividend payout ratio is 41.57%.